FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$11.72
-0.34 (-2.82%)
Open$12.10
Previous Close$12.06
Day High$12.26
Day Low$11.70
52W High$11.31
52W Low$5.65
Volume—
Avg Volume112.4K
Market Cap399.13M
P/E Ratio—
EPS$-0.28
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+154.3% upside
Current
$11.72
$11.72
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 55.08M | 74.30M | 77.18M |
| Net Income | -12,019,690 | -6,101,542 | -7,191,772 |
| Profit Margin | -21.8% | -8.2% | -9.3% |
| EBITDA | -10,246,178 | -9,610,170 | -10,191,915 |
| Free Cash Flow | — | -4,689,819 | -4,353,916 |
| Rev Growth | +207.2% | -7.2% | -5.1% |
| Debt/Equity | — | 0.51 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |